FindTrial
Sign In

Predicting the dominant secretory side of primary aldosteronism based on a contrast-enhanced CT radiomics-clinical fusion model

Predicting the dominant secretory side of primary aldosteronism based on a contrast-enhanced CT radiomics-clinical fusion model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124530
Enrollment
Unknown
Registered
2026-05-13
Start date
2025-11-15
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Aldosteronism

Interventions

Observation group:None

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >=18 years; 2.Diagnosed with Primary Aldosteronism (PA) via biochemical tests; 3.Completed enhanced computed tomography (CT) within 1 month before surgery; 4.Completed Adrenal Venous Sampling (AVS) examination; 5.Complete clinical data and available imaging data;

Exclusion criteria

Exclusion criteria: 1.Previous history of adrenal surgery; 2.Failed AVS cannulation (Selectivity Index [SI] < 2.0); 3.Severe artifacts in CT images that affect analysis; 4.Missing clinical data or imaging data;

Design outcomes

Primary

MeasureTime frame
Area under curve (AUC);—

Countries

China

Contacts

Public ContactLumin Chen

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

chenluminest@163.com+86 15168238975

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026